Junbing He

513 total citations
34 papers, 358 citations indexed

About

Junbing He is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Junbing He has authored 34 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Junbing He's work include Immune Response and Inflammation (12 papers), Sepsis Diagnosis and Treatment (5 papers) and Inflammation biomarkers and pathways (3 papers). Junbing He is often cited by papers focused on Immune Response and Inflammation (12 papers), Sepsis Diagnosis and Treatment (5 papers) and Inflammation biomarkers and pathways (3 papers). Junbing He collaborates with scholars based in China, South Korea and United Kingdom. Junbing He's co-authors include Yao Lin, Yiming Shao, Wenying Zhang, Furong Lu, Tian Zhao, Chuan Chen, Dongyang Long, Lili Cui, Yujie Cai and Zihan Yin and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Junbing He

33 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbing He China 12 110 105 80 47 42 34 358
Jiayu Wang China 14 133 1.2× 102 1.0× 116 1.4× 32 0.7× 35 0.8× 37 481
Jun Hong China 13 121 1.1× 71 0.7× 48 0.6× 47 1.0× 93 2.2× 16 384
Hui He China 14 186 1.7× 70 0.7× 73 0.9× 25 0.5× 40 1.0× 33 587
Arezou Khosrojerdi Iran 13 208 1.9× 125 1.2× 51 0.6× 34 0.7× 51 1.2× 31 458
Baorong Li China 11 159 1.4× 279 2.7× 39 0.5× 48 1.0× 33 0.8× 18 502
Sumith R. Panicker United States 12 109 1.0× 128 1.2× 50 0.6× 11 0.2× 32 0.8× 23 395
Xiaobing Wang China 17 184 1.7× 62 0.6× 59 0.7× 31 0.7× 52 1.2× 38 557
Qi Feng China 13 99 0.9× 51 0.5× 115 1.4× 38 0.8× 19 0.5× 40 468

Countries citing papers authored by Junbing He

Since Specialization
Citations

This map shows the geographic impact of Junbing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbing He more than expected).

Fields of papers citing papers by Junbing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbing He. The network helps show where Junbing He may publish in the future.

Co-authorship network of co-authors of Junbing He

This figure shows the co-authorship network connecting the top 25 collaborators of Junbing He. A scholar is included among the top collaborators of Junbing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbing He. Junbing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Xinyi, Jun Zhang, Yue Zhang, et al.. (2025). A pyrene-based red-emissive AIEE fluorophore based on ICT and ESIPT effects for bioimaging. Dyes and Pigments. 244. 113111–113111.
2.
Yao, Lin, et al.. (2025). Photodynamic therapy for oral candidiasis in human clinical trials: an evidence-based analysis. Photodiagnosis and Photodynamic Therapy. 54. 104729–104729. 1 indexed citations
3.
He, Junbing, et al.. (2024). Oxymatrine attenuates sepsis‐induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF‐κB signaling pathway. Drug Development Research. 85(4). e22219–e22219. 2 indexed citations
4.
He, Junbing, et al.. (2024). Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis. Frontiers in Medicine. 11. 1472019–1472019. 5 indexed citations
5.
He, Junbing, et al.. (2024). MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience-Landmark. 29(1). 44–44. 9 indexed citations
6.
Jiang, Wenxiao, et al.. (2024). X‐Ray‐Triggered CA IX Inhibition Nanoplatform Promotes Intratumoral Acidosis‐Induced Cancer Ferroptosis. Advanced Functional Materials. 35(13). 2 indexed citations
7.
Lin, Yao, et al.. (2024). Enamel matrix derivative in the treatment of tooth replantation: from a biological basis to clinical application. Annals of Medicine. 56(1). 2424452–2424452. 3 indexed citations
8.
He, Junbing, Yao Lin, Weiming Cai, et al.. (2023). EFFICACY OF SUPPLEMENTAL HEMOADSORPTION THERAPY ON SEVERE AND CRITICAL PATIENTS WITH COVID-19: AN EVIDENCE-BASED ANALYSIS. Shock. 60(3). 333–344. 4 indexed citations
9.
Lin, Yao, et al.. (2023). The conservative management for improving Visual Analog Scale (VAS) pain scoring in greater trochanteric pain syndrome: a Bayesian analysis. BMC Musculoskeletal Disorders. 24(1). 423–423. 5 indexed citations
10.
Lin, Yao, et al.. (2022). ADAM10-a “multitasker” in sepsis: focus on its posttranslational target. Inflammation Research. 72(3). 395–423. 10 indexed citations
11.
Lin, Yingying, et al.. (2022). A comparative evaluation of lasers and photodynamic therapy in the nonsurgical treatment of peri-implant diseases: A Bayesian network meta-analysis. Photodiagnosis and Photodynamic Therapy. 40. 103106–103106. 6 indexed citations
12.
Xu, Mingwei, et al.. (2022). Genetic Arg-304-His substitution in GRK5 protects against sepsis progression by alleviating NF-κB-mediated inflammation. International Immunopharmacology. 115. 109629–109629. 3 indexed citations
13.
He, Junbing, Tian Zhao, Furong Lu, et al.. (2021). The −172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria. International Immunopharmacology. 102. 108385–108385. 10 indexed citations
14.
Lu, Furong, et al.. (2021). Long noncoding RNAs: A potential target in sepsis-induced cellular disorder. Experimental Cell Research. 406(2). 112756–112756. 19 indexed citations
15.
Li, Ling, et al.. (2021). Beta1-integrin/Hedgehog-Gli1 signaling pathway fuels the diameter-dependent osteoblast differentiation on different TiO2 nanotubes. The International Journal of Biochemistry & Cell Biology. 137. 106026–106026. 20 indexed citations
17.
Lin, Yao, et al.. (2017). Role of Hedgehog–Gli1 signaling in the enhanced proliferation and differentiation of MG63 cells enabled by hierarchical micro-/nanotextured topography. International Journal of Nanomedicine. Volume 12. 3267–3280. 22 indexed citations
18.
Shao, Yiming, Lu Yin, Yuanli Zhang, et al.. (2017). Effect of continuous renal replacement therapy on kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury. Experimental and Therapeutic Medicine. 13(6). 3594–3602. 2 indexed citations
19.
Shao, Yiming, Feng Chen, Yuhua Chen, et al.. (2017). Association between genetic polymorphisms in the autophagy-related 5 gene promoter and the risk of sepsis. Scientific Reports. 7(1). 9399–9399. 26 indexed citations
20.
Shao, Yiming, Junbing He, Feng Chen, et al.. (2016). Association Study Between Promoter Polymorphisms of ADAM17 and Progression of Sepsis. Cellular Physiology and Biochemistry. 39(4). 1247–1261. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026